MMSI
Merit Medical Systems Inc
$
94.760
- Overview
- Forecast
- Valuation
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
96.350
Open
95.510
VWAP
95.22
Vol
883.99K
Mkt Cap
5.60B
Low
93.970
Amount
84.17M
EV/EBITDA(TTM)
20.63
Total Shares
58.11M
EV
5.98B
EV/OCF(TTM)
26.54
P/S(TTM)
4.13
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
384.17M
+8.17%
0.843
-9.37%
368.77M
+8.51%
0.789
-8.23%
372.14M
+10.1%
0.849
-7.69%
Estimates Revision
The market is revising Upward the revenue expectations for Merit Medical Systems, Inc. (MMSI) for FY2025, with the revenue forecasts being adjusted by 0.17% over the past three months. During the same period, the stock price has changed by -14.08%.
Revenue Estimates for FY2025
Revise Upward
+0.17%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-1.72%
In Past 3 Month
Stock Price
Go Down
-14.08%
In Past 3 Month
10 Analyst Rating
23.26% Upside
Wall Street analysts forecast MMSI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MMSI is 116.80 USD with a low forecast of 111.00 USD and a high forecast of 127.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
1 Hold
0 Sell
Strong Buy
23.26% Upside
Current: 94.760
Low
111.00
Averages
116.80
High
127.00
23.26% Upside
Current: 94.760
Low
111.00
Averages
116.80
High
127.00
Baird
David Rescott
Buy
Maintains
$111 → $110
2025-04-25
New
Reason
Baird
David Rescott
Price Target
$111 → $110
2025-04-25
New
Maintains
Buy
Reason
Baird analyst David Rescott lowered the firm's price target on Merit Medical to $110 from $111 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results which showed the tariff hit wil weigh on 2025 earnings but its CGI drivers keep 2026 unchanged.
Needham
Mike Matson
Strong Buy
Maintains
$116 → $100
2025-04-25
New
Reason
Needham
Mike Matson
Price Target
$116 → $100
2025-04-25
New
Maintains
Strong Buy
Reason
Barrington Research
Michael Petusky
Buy
Maintains
$111 → $103
2025-04-25
New
Reason
Barrington Research
Michael Petusky
Price Target
$111 → $103
2025-04-25
New
Maintains
Buy
Reason
Barrington analyst Michael Petusky lowered the firm's price target on Merit Medical to $103 from $111 and keeps an Outperform rating on the shares. Merit updated its FY25 guidance given the difficult tariff backdrop and it now sees non-GAAP EPS in a range of $3.29-$3.42, down from $3.58-$3.70, on an unchanged forecast for $1.47B-$1.49B in revenue, the analyst noted.
Raymond James
Jayson Bedford
Buy
Maintains
$116 → $108
2025-04-25
New
Reason
Raymond James
Jayson Bedford
Price Target
$116 → $108
2025-04-25
New
Maintains
Buy
Reason
Raymond James analyst Jayson Bedford lowered the firm's price target on Merit Medical to $108 from $116 and keeps an Outperform rating on the shares. The weakness in shares following the -8% revision in 2025 EPS guidance is a buying opportunity, the analyst tells investors in a research note. The lower guidance is due to the current tariff policies, but Merit has a line-of-sight into mitigation strategies that should reduce the impact by nearly 50% during 2026, the firm says.
Canaccord Genuity
Jon Young
Strong Buy
Maintains
$127 → $108
2025-04-25
New
Reason
Canaccord Genuity
Jon Young
Price Target
$127 → $108
2025-04-25
New
Maintains
Strong Buy
Reason
Canaccord analyst John Young lowered the firm's price target on Merit Medical to $108 from $127 and keeps a Buy rating on the shares. The firm said after a strong Q1 print, Merit's margin expansion story just got more complicated due to tariffs. Much of the investor thesis on Merit Medical has been on margin expansion and tariffs are creating a formidable hurdle to that continued pace of expansion.
Piper Sandler
Jason Bednar
Buy
Maintains
$116 → $112
2025-04-23
Reason
Piper Sandler
Jason Bednar
Price Target
$116 → $112
2025-04-23
Maintains
Buy
Reason
Piper Sandler lowered the firm's price target on Merit Medical to $112 from $116 and keeps an Overweight rating on the shares ahead of quarterly results. The firm notes that policy and broad economic uncertainty has seemingly created opportunities for investors to do value shopping. Piper continues to see Merit as one of its better 12-month ideas, but thinks this is a better name to own after Q1 given what the firm expects to be an overly conservative approach to tariff risk and Wrapsody commercial upside more tilted towards the second half of the year.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Merit Medical Systems Inc (MMSI.O) is 28.55, compared to its 5-year average forward P/E of 26.98. For a more detailed relative valuation and DCF analysis to assess Merit Medical Systems Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
26.98
Current PE
28.55
Overvalued PE
31.34
Undervalued PE
22.63
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
18.06
Current EV/EBITDA
19.12
Overvalued EV/EBITDA
19.79
Undervalued EV/EBITDA
16.32
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Overvalued
5Y Average PS
3.27
Current PS
3.76
Overvalued PS
3.73
Undervalued PS
2.82
Financials
Annual
Quarterly
FY2025Q1
YoY :
+9.84%
355.35M
Total Revenue
FY2025Q1
YoY :
+14.23%
41.03M
Operating Profit
FY2025Q1
YoY :
+6.75%
30.15M
Net Income after Tax
FY2025Q1
YoY :
+2.08%
0.49
EPS - Diluted
FY2025Q1
YoY :
-19.51%
19.05M
Free Cash Flow
FY2025Q1
YoY :
+3.22%
48.41
Gross Profit Margin - %
FY2025Q1
YoY :
+26.03%
12.83
FCF Margin - %
FY2025Q1
YoY :
-2.86%
8.48
Net Margin - %
FY2025Q1
YoY :
-1.28%
6.95
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
8.8M
USD
7
3-6
Months
9.8M
USD
6
6-9
Months
0.0
USD
0
0-12
Months
613.9K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 121.37% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
76.9K
Volume
2
Bought
0-3
0
0.0
Volume
Months
3-6
4
330.7K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
4
149.4K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
8.8M
USD
7
3-6
Months
9.8M
USD
6
6-9
Months
0.0
USD
0
0-12
Months
613.9K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
MMSI News & Events
Events Timeline
2025-04-24 (ET)
2025-04-24
16:18:35
Merit lowers FY25 EPS view to $3.29-$3.42 from $3.58-$3.70, consensus $3.65
2025-04-24
16:16:31
Merit Medical reports Q1 non-GAAP EPS 86c, consensus 75c
2025-04-09 (ET)
2025-04-09
09:27:25
Merit Medical launches Ventrax Delivery System
Sign Up For More Events
Sign Up For More Events
News
4.0
04-25BenzingaThe Analyst Verdict: Merit Medical Systems In The Eyes Of 17 Experts
4.0
04-25BenzingaCanaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $108
7.0
04-25SeekingAlphaMerit Medical outlines 2025 revenue growth of up to 10.2% despite tariff challenges
Sign Up For More News
People Also Watch
ALRS
Alerus Financial Corp
20.120
USD
+13.29%
GAIN
Gladstone Investment Corp
13.900
USD
-0.36%
GHM
Graham Corp
30.480
USD
-1.30%
ATRO
Astronics Corp
22.640
USD
+2.68%
AIRJ
Montana Technologies Corp
5.070
USD
+1.60%
IVR
Invesco Mortgage Capital Inc
7.470
USD
+0.95%
SENS
Senseonics Holdings Inc
0.750
USD
+3.88%
ANGO
AngioDynamics Inc
9.580
USD
+0.63%
PROK
ProKidney Corp
1.080
USD
+4.85%
SVRA
Savara Inc
3.260
USD
+2.19%
FAQ
What is Merit Medical Systems Inc (MMSI) stock price today?
The current price of MMSI is 94.76 USD — it has decreased -0.71 % in the last trading day.
What is Merit Medical Systems Inc (MMSI)'s business?
What is the price predicton of MMSI Stock?
What is Merit Medical Systems Inc (MMSI)'s revenue for the last quarter?
What is Merit Medical Systems Inc (MMSI)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Merit Medical Systems Inc (MMSI)'s fundamentals?
How many employees does Merit Medical Systems Inc (MMSI). have?